IL-1β was shown to promote the adhesion of cancer cells to endothelial cells in vitro, and administration of IL-1β to mice increased the number of lung and skeletal metastases, while reducing IL-1β activity in melanoma mouse models reduced tumor burden and metastases [173,174,175,176]. Here, IL1B is linked to melanoma.